The global glanders market size was significantly robust in 2022 and is expected to register a steady revenue CAGR over the forecast period. Key factors responsible for driving market revenue growth are the rising unmet needs and availability of various types of therapies across the globe.
Glanders mainly occurs in donkeys, mules, and horses. It is caused by a bacteria named Burkholderia Mallei. It is generally fatal and can be transmitted to humans. Poor feeding conditions, improper husbandry, and animal transport are few of the factors that can transmit glanders. Another common source of infection is ingestion of contaminated water or food.
The disease can take occur in different forms in humans, such as septicemic form (bloodstream), pulmonary infection (lungs), and local infection of skin (cutaneous). It can either occur through indirect contact with contaminated food, water, and soil or direct contact with infected animals and their secretions. Humans can avoid transmission of glanders by taking precautionary hygiene measures, avoiding contact with infected animals, and controlling the disease in animals.
Request a Sample@ https://www.qyresearchmedical.com/sample/119448
Major Factors Driving Growth Of The Global Glanders Market:
The glanders market is significantly driven by increasing improvements of technology, such as automated analyzers. At the same time, development of advanced devices are providing high output, performing numerous tests in a shorter duration of time, and reducing weight time significantly. Besides, surging safety concerns to control the disease would also boost growth. As clinical signs are not enough to confirm the disease, laboratory tests are very essential for the same. In addition to this, the World Organization for Animal Health (OIE) mentioned that potentially contaminated material should be handled in the laboratory as per the guidelines given by the organization.
Factors Restraining Growth Of The Global Glanders Market:
The global glanders market growth is substantially hampered by the unavailability of vaccines for the disease. Glanders is chronic, acute, contagious, and often fatal. Most other species are susceptible to the disease. It is considered to be a potential bioterrorism agent with a 95% fatality rate. Though it is one of the oldest diseases, in several countries, it has been effectively controlled or eradicated.
Opportunities For Players Operating In The Global Glanders Market:
At present, there is no vaccine available for glanders in the market. In the recent years, the disease has been reported in South America, India, China, Africa, the Middle East, Mongolia, Pakistan, and some parts of Europe. Thus, companies are mainly focusing on the introduction of vaccines for this disease. Once they are developed, the demand for treatment options is set to be very high in these regions and countries, thereby providing lucrative opportunities for growth.
Global Glanders Market Revenue Led By
Product Type Segment:
Based on product type, the market is segmented into tetracyclines, ciprofloxacin, streptomycin, novobiocin, gentamicin, imipenem, ceftazidime, and sulfonamides. As availability of treatment options for glanders is very rare worldwide, companies are conducting extensive research and development activities to introduce an effective vaccine for the disease. Hence, they are including the above-mentioned antibiotics in their studies for experimenting with humans and animals.
Global Glanders Market Leading End-use Segment:
Based on end-use, the market is segmented into hospitals, standard reference laboratories, public health laboratories, and others. Amongst these, the standard reference laboratories, public health laboratories segments are expected to show significant growth because of the availability of various treatment options for glanders in these places. These laboratories help in making vaccines for treating this disease.
Asia Pacific Continues To Lead In Terms Of Revenue CAGR:
The Asia Pacific glanders market is expected to register the fastest CAGR over the forecast period. In developing countries, such as Indonesia, Malaysia, China, and India, construction activities are rising at a fast pace. Along with this, rapid urbanization and surging initiatives by governments to develop the healthcare sector in these countries are expected to drive the APAC market growth in the near future. Europe, on the other hand, is anticipated to exhibit robust growth in terms of revenue, owing to increasing cases of glanders in some parts of the region. In North America, treatment of glanders is not permitted in the U.S. because of strict norms put forward by government organizations. It would hence showcase slow growth.
Major Companies Profiled In The Report:
- Bio-Rad laboratories
- Oxford Immunotec
- EIKEN CHEMICAL
- Thermo Fisher Scientific
Strategies And Objectives Of Major Companies:
- The demand for vaccines is increasing at a fast pace across the globe for providing protection to people who visit or live in endemic zones. Hence, numerous pharmaceutical companies are conducting R&D activities to come up with multiple vaccines by using antigen and adjuvant combinations.
- Live accentuated vaccines (LAV) were tested on several candidates over the past few years. But, all the tests have failed to showcase candidates’ immune power while combatting long-term effects of the disease. LAVs are commonly known for their ability to evoke cell-meditated and humoral immune responses for long-term protection.
- As LAVs proved to be non-responsive, organizations have now moved towards subunit vaccines. These are considered to be a suitable alternative to LAVs as they use a unique antigenic bacterial component to elicit an immune response. Besides, it is utilized for improving humoral and cellular immunity. However, subunit vaccines have only exhibited partial protection against glanders. It is yet to clear the pre-clinical testing.
- Rapid advancements in the field of nanotechnology has proved to be beneficial of the development of vaccines. This has provided manufacturers a chance to blend potent adjuvant simulation with antigen delivery for creating a broader immune response and offering promising vaccine models.
What Our Report Provides And Why Our Offering Is Better:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2023 to 2032. The global market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and market share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis. The report includes a detailed view of the global market, along with changing dynamics and trends, scenarios, detailed market and regional segmentation, regional landscape, analysis and evaluation, major investments, product offerings, product launches, and details of historical, current, and projected revenues.
Detailed Segmentation In Our Report:
For the purpose of this report, the global Glanders Market is segmented on the basis of product type, equipment, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2023-2032)
Equipment Outlook (Revenue, USD Billion; 2023-2032)
- Instruments/Analyzers & Software
- Testing equipment
End-use Outlook (Revenue, USD Billion; 2023-2032)
- Standard Reference Laboratories
- Public Health Laboratories
Region Outlook (Revenue, USD Billion; 2023-2032)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119448/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: